FDA's proposal to introduce user fees attracts low-key response from Congress
This article was originally published in Clinica
Executive Summary
There was surprisingly little reaction from Congress last week to the US FDA's proposal to impose $7 million in user fees on the medical device industry in fiscal 2000. Indeed, only two members of the House Appropriations subcommittee responsible for the FDA's budget even raised the issue at the agency's annual budget hearing.